These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8079818)
1. Lipoxygenase inhibitory activity of U-66,858 and its deacetylated metabolite U-68,244 in human whole blood. Summers JA; Bye A; Robinson C Agents Actions; 1994 Mar; 41(1-2):32-6. PubMed ID: 8079818 [TBL] [Abstract][Full Text] [Related]
2. Release of leukotrienes into the perfusate of calcium-ionophore stimulated rabbit lungs. Influence of 5-lipoxygenase inhibitors. Schulz R; Seeger W Biochem Pharmacol; 1986 Jan; 35(2):183-93. PubMed ID: 3002385 [TBL] [Abstract][Full Text] [Related]
3. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models. Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987 [TBL] [Abstract][Full Text] [Related]
4. Leukocyte mediated vein injury and thrombosis is reduced by a lipoxygenase inhibitor. Schaub RG; Yamashita A Exp Mol Pathol; 1986 Dec; 45(3):343-53. PubMed ID: 3025012 [TBL] [Abstract][Full Text] [Related]
5. Guinea pig whole blood 5-lipoxygenase assay: utility in the assessment of potential 5-lipoxygenase inhibitors. Spaethe SM; Snyder DW; Pechous PA; Clarke T; VanAlstyne EL Biochem Pharmacol; 1992 Jan; 43(2):377-82. PubMed ID: 1310855 [TBL] [Abstract][Full Text] [Related]
6. Effect of Zileuton (A-64077) on the 5-lipoxygenase activity of human whole blood ex vivo. Sirois P; Borgeat P; Lauzière M; Dubé L; Rubin P; Kesterson J Agents Actions; 1991 Sep; 34(1-2):117-20. PubMed ID: 1665285 [TBL] [Abstract][Full Text] [Related]
7. Ca2+ ionophore A23187-stimulated secretion of azurophil granules in human polymorphonuclear leukocytes is largely mediated by endogenously formed leukotriene B4. Hatzelmann A; Fruchtmann R; Mohrs KH; Raddatz S; Müller-Peddinghaus R Biochem Pharmacol; 1994 Jul; 48(1):31-9. PubMed ID: 8043028 [TBL] [Abstract][Full Text] [Related]
8. Receptor antagonism of leukotriene B4 myotropic activity by the 2,6 disubstituted pyridine analog U-75302: characterization on lung parenchyma strips. Lawson CF; Wishka DG; Morris J; Fitzpatrick FA J Lipid Mediat; 1989; 1(1):3-12. PubMed ID: 2562431 [TBL] [Abstract][Full Text] [Related]
9. Saiboku-To, a herbal extract mixture, selectively inhibits 5-lipoxygenase activity in leukotriene synthesis in rat basophilic leukemia-1 cells. Kobayashi I; Hamasaki Y; Sato R; Zaitu M; Muro E; Yamamoto S; Ichimaru T; Miyazaki S J Ethnopharmacol; 1995 Aug; 48(1):33-41. PubMed ID: 8569245 [TBL] [Abstract][Full Text] [Related]
10. Effect of manoalide on human 5-lipoxygenase activity. Cabré F; Carabaza A; Suesa N; García AM; Rotllan E; Gómez M; Tost D; Mauleón D; Carganico G Inflamm Res; 1996 May; 45(5):218-23. PubMed ID: 8737743 [TBL] [Abstract][Full Text] [Related]
11. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400 [TBL] [Abstract][Full Text] [Related]
12. Effects of racemic, S- and R-indobufen on cyclooxygenase and lipoxygenase activities in human whole blood. Patrignani P; Volpi D; Ferrario R; Romanzini L; Di Somma M; Patrono C Eur J Pharmacol; 1990 Nov; 191(1):83-8. PubMed ID: 1965501 [TBL] [Abstract][Full Text] [Related]
13. The effects of phosphodiesterase type 4 inhibitors on tumour necrosis factor-alpha and leukotriene B4 in a novel human whole blood assay. Brideau C; Van Staden C; Styhler A; Rodger IW; Chan CC Br J Pharmacol; 1999 Feb; 126(4):979-88. PubMed ID: 10193778 [TBL] [Abstract][Full Text] [Related]
14. Arachidonic acid metabolism in normal human alveolar macrophages: stimulus specificity for mediator release and phospholipid metabolism, and pharmacologic modulation in vitro and in vivo. Yoss EB; Spannhake EW; Flynn JT; Fish JE; Peters SP Am J Respir Cell Mol Biol; 1990 Jan; 2(1):69-80. PubMed ID: 2155013 [TBL] [Abstract][Full Text] [Related]
15. Leukotriene B4 production by stimulated whole blood: comparative studies with isolated polymorphonuclear cells. Gresele P; Arnout J; Coene MC; Deckmyn H; Vermylen J Biochem Biophys Res Commun; 1986 May; 137(1):334-42. PubMed ID: 3013186 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of inhibitors of eicosanoid synthesis in leukocytes: possible pitfall of using the calcium ionophore A23187 to stimulate 5' lipoxygenase. Salmon JA; Tilling LC; Moncada S Prostaglandins; 1985 Mar; 29(3):377-85. PubMed ID: 2988019 [TBL] [Abstract][Full Text] [Related]
17. Effects of tetrandrine on production of leukotriene B4 and thromboxane B2 in rabbit blood. Du ZY; Huang YH Zhongguo Yao Li Xue Bao; 1993 Jul; 14(4):325-8. PubMed ID: 8249626 [TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo. Tateson JE; Randall RW; Reynolds CH; Jackson WP; Bhattacherjee P; Salmon JA; Garland LG Br J Pharmacol; 1988 Jun; 94(2):528-39. PubMed ID: 2840160 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of leukotriene C4 and B4 release by human eosinophils with the new 5-lipoxygenase inhibitor 6-hydroxy-2(4-sulfamoylbenzylamino)-4,5,7-trimethylbenzothiazo le hydrochloride. Fukuda T; Numao T; Akutsu I; Toda M; Motojima S; Makino S Arzneimittelforschung; 1995 Sep; 45(9):1002-4. PubMed ID: 7488299 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of equine mononuclear cell proliferation and leukotriene B4 synthesis by a specific 5-lipoxygenase inhibitor, A-63162. Olsen SC; Atluru D; Atluru S; McVey DS; Erickson HH Am J Vet Res; 1992 Jun; 53(6):1015-8. PubMed ID: 1320811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]